Glaukos (GKOS) Change in Acquisitions & Divestments (2016 - 2026)
Glaukos' (GKOS) quarterly Change in Acquisitions & Divestments came in at $46.6 million in Q1 2026, up 13.94% year-on-year from $40.9 million in Q1 2025, and up 66.43% on a QoQ basis from $28.0 million in Q4 2025.
Glaukos (GKOS) Change in Acquisitions & Divestments (2016 - 2026) Analysis & Trends
Glaukos (GKOS) has 11 years of Change in Acquisitions & Divestments data on file, last reported at $46.6 million in Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments rose 13.94% year-over-year to $46.6 million in Q1 2026; TTM through Mar 2026 was $202.6 million, a 23.88% decrease from a year earlier, with the FY2025 full-year figure at $196.9 million, down 20.33% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $46.6 million, up from $28.0 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for GKOS reached as high as $107.0 million in Q2 2023 and fell as low as $17.2 million in Q1 2022.
- Historically, Change in Acquisitions & Divestments has averaged $54.6 million across 5 years, with a median of $46.6 million in 2026.
- Across the five-year window, Change in Acquisitions & Divestments surged 423.17% in 2023 and plunged 75.66% in 2024, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at $37.7 million in 2022, then soared by 70.9% to $64.4 million in 2023, then gained by 24.77% to $80.3 million in 2024, then tumbled by 65.15% to $28.0 million in 2025, then soared by 66.43% to $46.6 million in 2026.
- Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $46.6 million in Q1 2026, $28.0 million in Q4 2025, and $74.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Glaukos | 8.79 Bn | 8.68 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.58 Mn |
| Mar 31, 2026 | 46.58 Mn |
| Dec 31, 2025 | 27.98 Mn |
| Dec 31, 2025 | 27.98 Mn |
| Sep 30, 2025 | 74.54 Mn |
| Sep 30, 2025 | 74.54 Mn |
| Jun 30, 2025 | 53.53 Mn |
| Jun 30, 2025 | 53.53 Mn |
| Mar 31, 2025 | 40.88 Mn |
| Mar 31, 2025 | 40.88 Mn |
| Dec 31, 2024 | 80.31 Mn |
| Dec 31, 2024 | 80.31 Mn |
| Sep 30, 2024 | 65.16 Mn |
| Sep 30, 2024 | 65.16 Mn |
| Jun 30, 2024 | 79.85 Mn |
| Jun 30, 2024 | 79.85 Mn |
| Mar 31, 2024 | 21.88 Mn |
| Mar 31, 2024 | 21.88 Mn |
| Dec 31, 2023 | 64.37 Mn |
| Dec 31, 2023 | 64.37 Mn |